BANK VONTOBEL/CALL/MERCK & CO./100/0.1/21.06.24 Stock

Warrant

DE000VM525B4

Market Closed - Boerse Frankfurt Warrants 01:44:57 2024-06-14 pm EDT
2.78 EUR +0.36% Intraday chart for BANK VONTOBEL/CALL/MERCK & CO./100/0.1/21.06.24
Current month+17.30%
1 month+2.58%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-14 2.78 +0.36%
24-06-13 2.77 -4.15%
24-06-12 2.89 -2.36%
24-06-11 2.96 +1.72%
24-06-10 2.91 +1.39%

Real-time Boerse Frankfurt Warrants

Last update June 14, 2024 at 01:44 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM525B
ISINDE000VM525B4
Date issued 2023-11-28
Strike 100 $
Maturity 2024-06-21 (6 Days)
Parity 10 : 1
Emission price 0.72
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.17
Lowest since issue 0.67
Spread 0.01
Spread %0.36%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.5 USD
Average target price
142.7 USD
Spread / Average Target
+10.20%
Consensus